Thermo Fisher announces new spectrometers, facility, more

By The Science Advisory Board staff writers

September 8, 2021 -- Thermo Fisher Scientific announced that it is building a manufacturing facility in Tennessee. In addition, it has released a line of spectrometers and a liquid chromatography system.

The company plans to establish a manufacturing facility in Nashville dedicated to the production of single-use products. This building is in addition to Thermo Fisher Scientific's previously announced expansion. The facility, which is expected to begin construction in the second quarter of 2022, will be one of the world's largest manufacturing sites dedicated to single-use technologies (SUT) and will more than double the company's SUT manufacturing capacity.

In other news, the company announced its new TSQ Plus triple quadrupole mass spectrometer portfolio, which consists of TSQ Altis Plus, TSQ Quantis Plus, and TSQ Fortis Plus MS. The portfolio is designed to increase workflow throughput through data acquisition and polarity-switching speeds. The portfolio's improved low-mass product ion transmission efficiency enhances sensitivity for key target applications. In addition, it offers intuitive mass calibration routines and method optimization.

Finally, Thermo Fisher Scientific unveiled its new Vanquish neo ultra-high-performance liquid chromatography system. The system is an all-in-one nano-, capillary- and micro-flow liquid chromatography (LC) system designed for high-sensitivity LC-mass spectrometry applications, technical capabilities, and integration with Thermo Scientific's PepMap neo columns and mass spectrometry portfolio. It aims to overcome the limitations of existing low-flow LC instruments.


Copyright © 2021 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.